Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine improves PFS in N2-3 nasopharyngeal carcinoma

Talazoparib plus enzalutamide shows improvement in PFS over standard of care in firstline HRR mCRPC

Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis

Dostarlimab chemo combination for primary advanced or recurrent endometrial cancer

2L triple metronomic chemo shows more efficacy in comparison to systemic therapy for head and neck cancer

Next-generation selective RET inhibitor shows initial promise with RET-altered solid tumours

Trastuzumab deruxtecan gives strong anti-tumour activity and durable responses in multiple tumour types

PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo

Osimertinib after surgery significantly improves survival in resected EGFR-mutated NSCLC

ASCO 2023: Breast cancer research highlights

Ciltacabtagene autoleucel greatly reduces risk of disease progression in lenalidomide-refractory MM

mRCC: Atezolizumab after progression with prior ICI treatment shows no benefit and increases toxicity